This is a preview of subscription content, log in via an institution to check access.
References
Atkinson W, Slow S, Elmslie J, Lever M, Chambers ST, George PM (2009). Dietary and supplementary betaine: effects on betaine and homocysteine concentration in males. Nutr Metab Cardiovasc Dis 19, 767–773.
Konstantinova SV, Tell GS, Vollset SE Nygård O, Bleie Ø, Ueland PM (2008). Divergent associations of plasma choline and betaine with components of the metabolic syndrome in middle age and elderly men and women. J Nutr 138, 914–920.
Lever M, George PM, Dellow WJ, Scott RS, Chambers ST (2005). Homocysteine, glycine betaine and N,N-dimethylglycine in patients attending a lipid clinic. Metabolism 54, 1–14.
Lever M, Slow S (2010). The clinical significance of betaine, an osmolyte with a key role in methyl group metabolism. Clin Biochem 43, 732–744.
Olthof MR, van Vliet T, Boelsma E, Verhoef P (2003). Low dose betaine supplementation leads to immediate and long term lowering of plasma homocysteine in healthy men and women. J Nutr 133, 4135–4138.
Price RK, Keaveney EM, Hamill LL, Wallace JMW, Ward M, Ueland PM et al. (2010). Wheat aleurone-rich foods increase fasting plasma betaine and modestly decrease plasma homocysteine and LDL-cholesterol. J Nutr 140, 2153–2157.
Schwab U, Alfthan G, Uusitupa M (2011). Long-term effect of betaine on risk factors associated with the metabolic syndrome in healthy subjects. Eur J Clin Nutr 65, 70–76.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no conflict of interest.
Rights and permissions
About this article
Cite this article
Slow, S., Lever, M. & Elmslie, J. Betaine supplementation and the metabolic syndrome. Eur J Clin Nutr 65, 771 (2011). https://doi.org/10.1038/ejcn.2011.32
Published:
Issue Date:
DOI: https://doi.org/10.1038/ejcn.2011.32
- Springer Nature Limited
This article is cited by
-
Response to Slow et al.
European Journal of Clinical Nutrition (2011)